Analysts Set KindlyMD, Inc. (NASDAQ:NAKA) Price Target at $0.75

Shares of KindlyMD, Inc. (NASDAQ:NAKA) have earned an average recommendation of “Hold” from the five ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $0.75.

Several analysts recently weighed in on the stock. TD Cowen assumed coverage on shares of KindlyMD in a research report on Friday. They issued a “buy” rating and a $1.00 price objective on the stock. B. Riley Financial cut their price objective on shares of KindlyMD from $1.00 to $0.50 and set a “buy” rating on the stock in a research report on Monday, February 23rd. Maxim Group cut their price objective on shares of KindlyMD from $1.50 to $0.75 and set a “buy” rating on the stock in a research report on Monday, April 6th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of KindlyMD in a research note on Friday, March 27th.

Institutional Investors Weigh In On KindlyMD

Hedge funds and other institutional investors have recently modified their holdings of the stock. Van ECK Associates Corp bought a new stake in shares of KindlyMD during the third quarter valued at about $111,339,000. Vanguard Group Inc. raised its stake in shares of KindlyMD by 32,737.0% during the third quarter. Vanguard Group Inc. now owns 6,036,750 shares of the company’s stock valued at $150,557,000 after purchasing an additional 6,018,366 shares in the last quarter. Yorkville Advisors Global LP bought a new stake in shares of KindlyMD during the third quarter valued at about $231,942,000. Correct Capital Wealth Management bought a new stake in shares of KindlyMD during the third quarter valued at about $111,339,000. Finally, RK Capital Management LLC FL bought a new stake in shares of KindlyMD during the third quarter valued at about $239,052,000.

KindlyMD Price Performance

Shares of NASDAQ:NAKA opened at $0.22 on Friday. The company has a market cap of $150.98 million, a PE ratio of -0.25 and a beta of 26.73. The company’s 50-day moving average price is $0.25 and its 200 day moving average price is $0.49. KindlyMD has a fifty-two week low of $0.21 and a fifty-two week high of $34.77.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.